BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:37 PM
 | 
Jul 24, 2009
 |  BC Extra  |  Company News

CHMP backs Ilaris, Arcalyst

EMEA's CHMP issued several positive opinions on Friday, including recommendations for cryopyrin-associated periodic syndromes (CAPS) treatments from Novartis AG (NYSE:NVS; SIX:NOVN) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN). Novartis' Ilaris canakinumab is...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >